These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1104 related items for PubMed ID: 25056161

  • 1. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 2. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 3. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 4. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK, Kirkilesis GI, Tsolakis IA.
    Eur J Vasc Endovasc Surg; 2014 Nov 21; 48(5):565-75. PubMed ID: 24951377
    [Abstract] [Full Text] [Related]

  • 5. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A, Terleira-Fernández AI, Lecumberri R, Suárez-Gea ML, Vargas-Castrillón E.
    Thromb Res; 2014 Oct 21; 134(4):774-82. PubMed ID: 25037495
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Skjøth F, Larsen TB, Rasmussen LH, Lip GY.
    Thromb Haemost; 2014 May 05; 111(5):981-8. PubMed ID: 24577485
    [Abstract] [Full Text] [Related]

  • 7. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 05; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 8. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
    Nieto JA, Espada NG, Merino RG, González TC.
    Thromb Res; 2012 Aug 05; 130(2):183-91. PubMed ID: 22425218
    [Abstract] [Full Text] [Related]

  • 9. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
    Douketis J, Bell AD, Eikelboom J, Liew A.
    Can Fam Physician; 2014 Nov 05; 60(11):989-95. PubMed ID: 25392438
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
    Lip GY, Kongnakorn T, Phatak H, Kuznik A, Lanitis T, Liu LZ, Iloeje U, Hernandez L, Dorian P.
    Clin Ther; 2014 Feb 01; 36(2):192-210.e20. PubMed ID: 24508420
    [Abstract] [Full Text] [Related]

  • 11. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M.
    Clin Ther; 2013 Jul 01; 35(7):967-984.e2. PubMed ID: 23870607
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists.
    Levy JH.
    Clin Lab Med; 2014 Sep 01; 34(3):443-52. PubMed ID: 25168936
    [Abstract] [Full Text] [Related]

  • 13. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
    Sardar P, Chatterjee S, Lavie CJ, Giri JS, Ghosh J, Mukherjee D, Lip GY.
    Int J Cardiol; 2015 Jan 20; 179():279-87. PubMed ID: 25464465
    [Abstract] [Full Text] [Related]

  • 14. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Banerjee A, Lane DA, Torp-Pedersen C, Lip GY.
    Thromb Haemost; 2012 Mar 20; 107(3):584-9. PubMed ID: 22186961
    [Abstract] [Full Text] [Related]

  • 15. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.
    Douketis J, Bell AD, Eikelboom J, Liew A.
    Can Fam Physician; 2014 Nov 20; 60(11):997-1001. PubMed ID: 25392439
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
    Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):480-6. PubMed ID: 22787066
    [Abstract] [Full Text] [Related]

  • 17. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW, Barillari G.
    J Clin Pharm Ther; 2014 Apr 01; 39(2):118-35. PubMed ID: 24383983
    [Abstract] [Full Text] [Related]

  • 18. Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.
    Harenberg J, Marx S, Dahl OE, Marder VJ, Schulze A, Wehling M, Weiss C.
    Thromb Haemost; 2012 Nov 01; 108(5):903-12. PubMed ID: 23014668
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.
    Cohen A, Drost P, Marchant N, Mitchell S, Orme M, Rublee D, Simon TA, Sutton A.
    Clin Appl Thromb Hemost; 2012 Nov 01; 18(6):611-27. PubMed ID: 22387582
    [Abstract] [Full Text] [Related]

  • 20. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G, Becattini C, Franco L.
    Best Pract Res Clin Haematol; 2013 Jun 01; 26(2):151-61. PubMed ID: 23953903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.